FDA Gets Senate Funding, House Scolding In FY 2015 CR-Omnibus
This article was originally published in The Pink Sheet Daily
Executive Summary
Spending agreement would give FDA about a 1.3% increase from the fiscal year 2014 enacted appropriations legislation.
You may also be interested in...
Ebola Treatments Could Be Orphan Candidates – But Vaccines, Probably Not
FDA expects few people would get the disease in the U.S., but many could receive a vaccine.
FDA Opioid Guidance Is Silent On Generics, Cautions That Addicts Can Erase Labeling
Draft guidance on abuse-deterrent opioids notes that labeling claims may be revised if abusers outwit the abuse-resistant technology; the agency’s evaluation of generic-related citizen petitions continues.
Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director
Nicole Verdun said children could participate in gene therapy clinical trials earlier if the necessary controls are in place.